Earlier studies demonstrated enhancement of SARS-CoV-2 infection by NTD-binding mAbs in high-ACE2 expressing 293T cells and Huh7 cells, a human liver carcinoma cell line that expresses ACE2 [20, 39]. This evidence concerns the gene ACE2 and hepatocellular carcinoma.